Our Look at "American Patients First"
By AmerisourceBergen |
While campaigning for the Presidency, Donald Trump promised to lower drug prices for Americans. On Friday, May 11, President Trump shared his blueprint to lower drug prices, “American Patients First.” What does this mean for the healthcare industry? Read summaries and perspectives from across AmerisourceBergen’s business to understand what this might mean for stakeholders from manufacturers to dispensers and the drug wholesale industry.
Xcenda’s Health Policy Weekly shared a summary of the proposal including the key strategies outlined for reform and where there may be immediate action versus future opportunities. Reactions from industry stakeholders including COA, PhRMA and PCMA are also included.
Access the full "Special Edition Update" from Xcenda.
Access the full article, which includes an update on "Drug Pricing Activity" on Our Independent Voice.